10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $344,062,043 | -27.5% | 8,340,898 | -1.9% | 0.31% | -22.3% |
Q2 2023 | $474,877,153 | -2.8% | 8,504,247 | -2.9% | 0.40% | -8.4% |
Q1 2023 | $488,384,935 | +55.8% | 8,753,987 | +1.8% | 0.44% | +34.9% |
Q4 2022 | $313,465,444 | +30.4% | 8,602,235 | +1.9% | 0.33% | +31.9% |
Q3 2022 | $240,467,000 | -36.6% | 8,443,388 | +0.8% | 0.25% | -36.2% |
Q2 2022 | $379,148,000 | -32.2% | 8,378,971 | +13.9% | 0.39% | -0.8% |
Q1 2022 | $559,552,000 | -45.4% | 7,355,764 | +6.9% | 0.39% | -30.2% |
Q4 2021 | $1,024,603,000 | +27.0% | 6,878,377 | +24.1% | 0.56% | +33.2% |
Q3 2021 | $806,896,000 | -18.1% | 5,542,625 | +10.2% | 0.42% | -12.1% |
Q2 2021 | $985,169,000 | +289.9% | 5,030,996 | +260.4% | 0.48% | +240.4% |
Q1 2021 | $252,698,000 | +130.3% | 1,396,126 | +80.1% | 0.14% | +131.1% |
Q4 2020 | $109,743,000 | +72.1% | 775,020 | +51.5% | 0.06% | +38.6% |
Q3 2020 | $63,767,000 | +16506.0% | 511,447 | +11802.4% | 0.04% | – |
Q2 2020 | $384,000 | +287.9% | 4,297 | +170.4% | 0.00% | – |
Q1 2020 | $99,000 | – | 1,589 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |